Walk In Interview for Recruitment At AIIMS Jodhpur: SR Post In Various Dpt, Check Eligibility

Jodhpur: The All India Institute of Medical Sciences (AIIMS Jodhpur) has release vacancies for the Senior Resident post on a Contract Basis. The selection will be on the basis of the interview. 

AIIMS Jodhpur is one of the 6 new AIIMS established by the Ministry of Health & Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY) to correct regional imbalances in quality tertiary level healthcare in the country and attain self-sufficiency in graduate and postgraduate medical education.

AIIMS Jodhpur Vacancy Details:

Total No of Vacancies: 35

The Vacancies are in the Department of Anaesthesiology, Anatomy, Burns and Plastic Surgery, Community Medicine & Family Medicine, Interventional Radiology, Medicine, Microbiology, Nuclear Medicine, Gynaecology, Ophthalmology, ENT, Paediatrics, Pharmacology, Radio-Therapy, School of Public Health, and Transfusion Medicine & Blood Bank

Date of Walk-of-Interview:- 12th March 2025.

Venue and Reporting Time for Candidates Morning:- Medical College of AIIMS, Jodhpur at 09:00AM to 12:00 Noon

For more details about Qualifications, Age, Pay Allowance, and much more, click on the given link:
https://medicaljob.in/jobs.php?post_type=&job_tags=AIIMS+Jodhpur&location=&job_sector=all

Instructions for eligible candidates:-

Documents To Be Produced In Original At The Time of Interview:-

The Candidate should bring following original documents and one set of self-attested photocopies at the time of Interview with application form:-

i. Identity Proof (PAN Card, Passport, Driving License, Voter Card, Aadhar Card etc.) and Address Proof.

ii. Certificate showing Date of Birth (Passport/Birth Certificate/Driving License).

No Age relaxation would be available to SC/ST/OBC candidates applying for unreserved vacancies.

iii. Class 10th & 12th Marksheet and Certificates. iv. Qualifying degree1. MBBS/M.Sc Marksheet and degree certificates.

2. MD/DNB/MS/Ph.D degree certificate.

3. DM/M.Ch/DNB degree certificates.

v. Attempt and Internship Certificate.

vi. Registration with Medical Council of India/State Medical Council.

vii. Experience Certificate (if have).

viii. FMGE certificate conducted by NBE (For foreign graduate).

ix. Reservation category Certificate (OBC*/SC/ST/PwBD) (*Candidate should belong to non-creamy layer of Central List of OBC).

x. In case of OBC candidate, the OBC certificate must be issued within one year (Older certificate will not be entertained).

xi. No Objection Certificate (NOC), if candidate is working in Government Institution.

xii. Publications.

Note: Candidates who do not produce the above mentioned original documents at the time of interview will not be considered for selection.

Also Read:SAIL Recruitment 2025: Walk In Interview For Specialist, GDMO Post At Burnpur Hospital, Apply Now

Powered by WPeMatico

J.B Chemicals & Pharma announces DJSI score of 77

Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced that latest ESG score has been announced by Dow
Jones Sustainability Index (DJSI), one of the world’s premier indexes in terms of
sustainability.

J. B. Chemicals & Pharmaceuticals Limited’s DJSI score is 77, which will rank presently among the leading pharmaceutical companies in
India and also rank among the leaders in Pharma Globally (Sector: DRG Pharmaceuticals,
DJSI, S&P Global).

“This achievement underscores the Company’s steadfast commitment to
sustainability, corporate responsibility, and environmental, social, and governance (ESG)
excellence,” JB Chemicals stated.

The DJSI ranking is a premier globally recognized benchmark for corporate sustainability,
assessing companies with rigorous evaluation covering Environmental, Social and
Governance and industry specific questionnaires, assessing an average of 23 sustainability
topic through 150 questions/indicators, evaluating around 13,000 companies worldwide
every year.

“JB Pharma’s score reflects its continuous efforts to integrate sustainable practices
into its core business operations.
Over the past year, JB Pharma has implemented several impactful sustainability initiatives,
including renewable energy adoption, rainwater harvesting project, waste reduction
programs, increased governance, community development projects etc. These efforts have
not only contributed to a positive environmental and social footprint but have also
strengthened the Company’s position as a leader in sustainable growth,” it added.

“As JB Pharma continues its journey towards a more sustainable future, it remains committed to upholding the highest standards of corporate governance and responsible business practices, ensuring long-term value creation for all stakeholders,” it further added.

Read also: Q2 results: JB Chemicals & Pharma reports 36 percent rise in profit after tax at Rs 151 crore

J.B. Pharma was established in 1976. Besides its strong India presence, which accounts for majority of its revenue, its other two
home markets are Russia and South Africa. In India, the company has six brands among the top 300
IPM brands in the country. The company exports its finished formulations to over 40 countries including
the USA. Besides supplying branded generic formulations to several countries, it is also manufactures medicated lozenges. It has eightstate of the art manufacturing facilities in India including
a dedicated manufacturing facility for lozenges. The manufacturing facilities are certified by leading
regulators across the world.

Powered by WPeMatico

From State Medical Council Functioning to Doctor Shortage: CAG report flags gaps in Rajasthan Healthcare, Check out key takeaways

Jaipur: The Comptroller and Auditor General of India‘s audit of Public Health Infrastructure and Management of Health Services in Rajasthan revealed that neither the composition nor the functioning of the Rajasthan Medical Council was in accordance with the requirements of the Rajasthan Medical Act.  In this regard, the CAG report called for the State Government’s action to monitor the functioning of the State Medical Council to ensure effective regulation by the body.

The Performance Audit, covering the period between 2016-2022, assessed the healthcare services provided in the State of Rajasthan.

It examined whether the Government of Rajasthan took adequate measures to ensure adequate availability of infrastructure and healthcare services, drugs, medicines, equipment, and human resources to beneficiaries.

Here are the key takeaways:

(1) Shortage of Doctors, and Specialists: 

In the report, the Audit observed that the State was reeling under a shortage of doctors, specialists, nurses, and paramedics in the primary, secondary, and tertiary healthcare institutes.

“The State Government should address the shortage of health care professionals in a time-bound manner by adopting a clearly defined recruitment strategy as well as ensuring their equitable distribution across the State,” mentioned the Audit.

(2) Essential Minimum Assured Services Deficient in IPD of Government Medical Institutes: 

The Audit observed that essential minimum assured services like General Surgery, Paediatrics, Orthopaedics, and Accident and Trauma Wards were deficient in IPD of the Government Medical Institutions (GMIs). Further, it also noted that there were deficiencies in services such as Emergency, Intensive Care Units, Blood Banks of GMIs. 

In this regard, the CAG report opined that the State should ensure availability of the required Minimum Assured Services, like General Surgery, Paediatrics, Orthopaedics, Emergency, Intensive Care Unit, Blood Banks, etc. as per IPHS in the GMIs of the State.

(3) Non-availability of Radiology, Pathology, Dietary, Ambulance and Mortuary Services: 

The CAG report took note of the non-availability of adequate Radiology, Pathology, Dietary, Ambulance, and Mortuary services as per IPHS in the test-checked GMIs.

The Radiology service is available in 12 DHs out of 34 DHs, Pathology services are partially available in all 34 DHs, Dietary services are available in 18 out of 34 DHs, Ambulance services are available in 7 out of 34 DHs, and Mortuary service is available only in one DH our of the 34 DHs, revealed the audit.

Addressing the issue, the audit opined that the State Government should make efforts to provide adequate services such as Radiology, Pathology, Dietary, Ambulance and Mortuary Services as per IPHS in the GMIs of the State.

(4) Shortfall of essential drugs: 

As per the CAG report, the State had a shortfall of availability of essential drugs in test-checked GMIs and district drug warehouses. For this, the audit advised the State to take necessary steps to ensure sufficient availability of essential drugs in the hospitals and drug warehouses.

Audit observed that medicines issued to medical units were less than the quantity demanded and that there were delays in finalizing rate contracts. It was also observed that purchase orders were placed when the buffer stock was much less than the prescribed buffer level.

In this regard, the CAG report advised the State to specify the re-order point at which purchase orders are placed and put in place a mechanism of system-generated purchase orders for maintenance of prescribed buffer stocks.

(5) Delay in Test Reports: 

The audit also highlighted that there were delays in the receipt of quality test reports from the laboratories which resulted in the delay in issuing medicines by the warehouses to the medical units, contributing to the non-availability of medicines at the medical units. Addressing this, the audit asked the State to ensure timely testing of drug samples and receipt of quality test reports on time.

Taking note of the fact that test-checked GMIs purchased drugs locally without quality test reports, the audit asked the State to ensure issue of drugs to GMIs only after receipt of quality test reports.

(6) Inadequate equipment: 

The CAG report noted that equipment required as per Indian Public Health Standards (IPHS) in various categories was not available in the test-checked GMIs and therefore, the audit asked the State to ensure availability of essential equipment in the GMIs as per IPHS, as well as their periodic maintenance and calibration.

(7) Inadequate Health Facilities in Rural areas: 

While assessing the healthcare infrastructure across the desert, tribal, and plain areas of the State, the audit noted that there were shortage of healthcare facilities as the State did not have a concrete plan to address the shortage and prioritise areas with shortfall for setting up of healthcare infrastructure.

Accordingly, the audit advised the State to ensure availability of healthcare institutes as per the Indian Public Health Standards in the State and their equitable distribution to make healthcare accessible for all.

(8) Deficiencies in Basic Amenities: 

The audit also noticed deficiencies in the provision of basic amenities like separate toilet facilities for male and female, electricity, and potable drinking water in the Government Medical Institutions (GMIs) of the State and asked the Government to ensure availability of basic amenities like separate toilet facilities, electricity and potable drinking water in all the Government Medical Institutions of the State.

(9) Expenses in Healthcare Sector: 

Noting that the capital expenditure constituted only 6.67 per cent of the total expenditure on healthcare, the Audit asked the State Government to make efforts to augment the capital expenditure in healthcare sector.

The percentage of out-of-pocket expenditure to total health expenditure decreased in Rajasthan during the period 2016-20. However, it constituted 47.40 per cent of total healthcare expenditure during 2019-20, indicating low financial protection available to households towards healthcare payments in the State, it noted.

Accordingly, it directed the State Government to take necessary steps to increase the budgetary allocation for healthcare sector both as a percentage of State Budget as well as Gross State Domestic Product in line with the National Health Policy.

(10) Non Functioning Health and Wellness Centres: 

The audit asked the State to ensure proper functioning of Health and Wellness Centres as envisaged under the Ayushman Bharat-Health Wellness Centre as it noted that there was non-availability of required tests, non-conduct of Yoga sessions, and inadequate screening of Non-Communicable Diseases in adults in the Health and Wellness Centres established under Ayushman Bharat scheme in the State.

(11) Delay in Renewing Drug Manufacturing Licenses: 

In the CAG report, the delays in issuing and renewing of drug manufacturing licenses were highlighted and it also noted that the regular annual inspections were not carried out in any of the test-checked manufacturing units.

Addressing the issue, the State Government was advised to ensure that issue and renewal of manufacturing licenses are done in a time-bound manner and annual inspections are conducted regularly.

(12) Delayed Action Against Firms Manufacturing Below Quality Drugs: 

The Audit also noted that the action against firms manufacturing Not of Standard Quality drugs was significantly delayed. Accordingly, it opined that the State Government should fix responsibility of officers concerned for failure to ensure timely and appropriate action against the manufacturers of Not of Standard Quality Drugs.

(13) Issues in Rajasthan Medical Council and State Pharmacy Council: 

Regarding the Rajasthan Medical Council, the audit observed that neither the composition nor the functioning of the Council was in accordance with the requirements of Rajasthan Medical Act. It also noted that the State Pharmacy Council had not appointed Pharmacy Inspectors in the State.

The audit opined that the State Government should monitor the functioning of the State Medical Council and State Pharmacy Council to ensure effective regulation by these bodies.

Finally, noting that the State of Rajasthan had not formulated any vision/roadmap/strategy for achievement of Sustainable Development Goals (SDGs), it asked the State Government to expedite the alignment of SDGs with the State Government Vision 2030.

Also Read:Delhi Healthcare- Here are 7 shortcomings listed by CAG report

Powered by WPeMatico

Bayer arm advances Gene therapy clinical trial for Limb-Girdle Muscular Dystrophy Type 2I/R9

Research Triangle Park: AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has announced the advancement of the Phase 1/Phase 2 LION-CS101 clinical trial of investigational gene therapy AB-1003 in patients with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9) with dosing of the first participant in the second cohort.

The recommendation to advance to the second cohort followed the completion of a Data Safety Monitoring Board (DSMB) review of trial recruitment activity, and safety reporting from the first cohort that determined it was safe to proceed to cohort two. DSMBs are independent groups of experts appointed to periodically review information from clinical trials. These reviews typically include risk-benefit assessments and monitoring for serious or unexpected adverse safety events alongside any significant benefit of therapies.

The LION-CS101 clinical trial is a double-blind, randomized, placebo-controlled, dose-escalation clinical trial to evaluate the safety of AB-1003 gene therapy in adult participants (18–65 years) who have genetic confirmation of LGMD2I/R9. The trial includes two sequential, dose-level cohorts. Adult participants diagnosed with LGMD2I/R9 will be given a single intravenous infusion of AB-1003 or placebo.

The trial was initiated in 2023. It will include up to 14 participants at six sites throughout the United States. Participants in the first cohort remain in the study until completion. Enrollment in cohort two is ongoing. For more information about the LION-CS101 clinical trial, visit clinicaltrials.gov (NCT05230459) or askbio.com.

“The burden of LGMD2I/R9 on patients and their families is profound,” said Nicholas Johnson, MD, Principal Investigator and Vice Chair of Research at the Department of Neurology, Virginia Commonwealth University School of Medicine. “Dosing the first participant in the second cohort of the trial is positive news for people living with LGMD2I/R9. This is a rare and debilitating type of muscular dystrophy, and this advancement brings the LION-CS101 trial another step closer to completion.”

AskBio has received rare pediatric disease designation (RPDD), orphan-drug designation (ODD) and fast track designation (FTD) for AB-1003 for the potential treatment of LGMD2I/R9 from the United States Food and Drug Administration (FDA). These designations serve as clear recognition of the significant unmet medical need in LGMD2I/R9, for which there is no approved therapy.

“The dosing of the first participant in cohort two marks an important milestone for the trial as enrollment continues for LION-CS101,” said Canwen Jiang, MD, PhD, Chief Development Officer and Chief Medical Officer, AskBio. “We are encouraged by the DSMB’s recommendation to advance our study, following their thorough assessment of AB-1003 in cohort one and are excited to proceed with the second cohort.”

AB-1003 is an investigational recombinant adeno-associative virus (AAV)-based gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been fully established or evaluated. It is designed to restore FKRP enzyme activity, primarily inside muscle cells, for the treatment of LGMD2I/R9 as a one-time intravenous (IV) infusion.

Read also: Bayer AG arm AskBio names Mansuo Shannon as Chief Scientific Officer

Powered by WPeMatico

South Korea Freezes Medical School Admissions Amid Doctor Dispute

Seoul: South Korea’s Ministry of Education announced on Friday that it would freeze the number of new medical students at about 3,000 annually, following a 13-month prolonged dispute with trainee doctors. 

Thousands of such doctors have walked off the job since February 2024 to protest against a government plan to add more students in medical schools, as both sides disputed the remedies needed to fix the healthcare system in a rapidly ageing nation, reports Reuters.

Education Minister Lee Ju-ho set a deadline of the end of March for the return of all trainee doctors if the plan is to go ahead, however.

Also Read:South Korea urges doctors to join talks over ongoing walkout

“Our government’s position that the medical school quota should be increased has not changed,” Lee said. “But restoring trust between the medical community and the government is also very important.”

The long drawn-out dispute led to overstretched emergency care facilities, and delays or cancellations to surgeries.

In a post on Facebook, Park Dan, the head of the Korean Intern Resident Association that represents the trainee doctors, said he felt no need to respond to the government’s “threat”.

The main lobby group for doctors, the Korean Medical Association, said it was up to medical students to decide how to respond to the government’s offer, but it called the plan to boost the quota a “failed policy” and urged fresh talks.

Friday’s offer from the education ministry is a step back by the government after the administration of impeached President Yoon Suk Yeol took a firm line in trying to push through its medical reforms.

The government had planned an increase of 2,000 in medical school admissions from 2025, versus 3,000 now, to meet a large projected shortfall of doctors by 2035.

Authorities have said more doctors were required in remote areas, but many doctors said pay and work conditions were skewing the healthcare system and should be tackled first.

In January, the health ministry said about 90% of trainee doctors had resigned, from 13,531 eligible for hospital appointments. Medical students also walked out of classrooms, and few have returned.

Lee Jong-tae, president of the Korea Association of Medical Colleges, said he believed students would now return to school.

“I am asking all of us to work to have our students come back now,” Lee added.

Yoon was impeached over his short-lived imposition of martial law last year. His December 3 decree set a 48-hour deadline for all medical personnel to return to work, including trainee doctors who had left their jobs.

Much of the public initially backed the idea of boosting the number of medical students, but the impact of the walkout on the medical system had started to erode support.

The government had little choice but try to resolve the stalemate now public support had soured, with the situation worsened by Yoon’s impeachment, said Shin Yul, a professor of political science at Myongji University.

“Now the majority want Yoon to be removed from office,” he added. “The mood is not favourable for the government, and the government wants to minimise any problems.”

Also Read:Korean Govt to allow conditional leave for students protesting medical school quota hike

Powered by WPeMatico

Rajasthan NEET PG Special Stray Vacancy Round Counselling 2024 Begins, check out details

Rajasthan- The Rajasthan Counselling Board has begun the allotment process of National Eligibility and Entrance Test-Postgraduate (NEET PG) Special Stray Vacancy Round Counselling for the academic 2024. In this regard, the Rajasthan Counselling Board has released the complete schedule for the candidates who are willing to participate in the Special Stray Vacancy Round allotment process for MD/MS, Post MBBS DNB and Post MBBS Diploma courses in Rajasthan.

In continuation to the earlier notifications and NBE notification reducing the qualifying percentile of NEET PG 2024, the schedule for the special stray vacancy round allotment process for MD/MS, Post MBBS DNB and Post MBBS Diploma courses in Rajasthan, will be as below:

Schedule for Allotment process – Special Stray Vacancy Round

Details Date
Application form Start date for filling of on-line application form and
deposition of required
application fee
It is a mandatory step for subsequent process of counseling and
allotment.
Both the parts (Part 1 and Part 2) of the application form must be filled
and completed.
Those candidates who could not complete both the parts (Part 1 and Part 2)
of the
application form earlier, may now complete the same.
Those who are already registered/have applied need not register/apply again.
Note: Candidates who have a joined status after stray vacancy round will
not be allowed to participate in the
special stray vacancy round. Candidates who were allotted/upgraded a seat
in round 2/3/stray vacancy round
but not joined as well as candidates who resigned with forfeiture of
security amount will not be allowed
participation in special stray vacancy round

08.03.2025
Last date for depositing the application fee at the website 10.03.2025
(5.00 pm)
Last date for submitting the on-line application form at the
website		 10.03.2025
(11.45 pm)
Verification and submission of original documents (off-line) and
bond of
all eligible registered candidates willing to participate in Special Stray
Vacancy
Round – at Academic Block, SMS Medical College, Jaipur
Note: Documents of candidates who wish to participate in Special stray
vacancy
round will be kept by the counselling board after verification. Candidate
shall
also submit a Bond in prescribed format available at website. 		10.03.2025
to 13.03.2025 (10:00 AM to 4:00 PM)
Publication of Provisional Seat Matrix 08.03.2025
Publication of Provisional Merit List of Registered Candidates
Eligible to participate in Special Stray Vacancy Round		 13.03.2025
Tentatively (Subject to receipt of Merit List from NBE)
Deposition of security amount (refer the Instructions Booklet
for details)
Candidates who have deposited the security amount in Round 1 or Round 2 or
Round 3 or stray vacancy
round but not allotted a seat in any round, need not deposit in Special
Stray Vacancy Round.		 10.03.2025
to 13.03.2025 (4.00 pm)
On-line choice filling, locking of the choices
by the candidates (including filling up
and saving of the choices / changing the filled choices multiple
times)
Choices filled by candidates (not holding any seat up to stray vacancy
round) in Round 1
/ Round 2 / Round 3 / Stray Vacancy Round will not be considered for
Special Stray
Vacancy Round allotment.

Following candidates are eligible for Special Stray Vacancy Round and must
fill choices to participate in
Special Stray Vacancy Round:
1. Earlier registered candidates who did not get allotment in Round 1,
Round 2, Round 3 and
Stray Vacancy Round
2. Round 1 candidate allotted and joined but resigned after Round 2 without
forfeiture of
security amount and not allotted any seat in round 3 / Stray Vacancy
Round
3. All Newly Registered Candidates of Special stray vacancy round

 10.03.2025
to 14.03.2025 (11.45 pm) (choices auto-locked at 11.45 pm
on 14.03.2025)
Verification of Disability certificate (issued by 16 centers
approved by MCC) of all persons
with disabilities (PwD), candidates of all categories (at 9.00 am sharp at
Academic Block,
SMS Medical College, Jaipur)
All such candidates (not verified upto stray vacancy round and willing to
participate in special
stray vacancy round) must present themselves physically along with all
original relevant
documents, before the Board		 16.03.2025,
10.00 am
Tentatively
(Subject to receipt of Merit
List from NBE)
Verification, Allotment and Reporting by State NEET PG 2024
Registered Eligible Sr.
Demonstrator candidates for In-Service Quota (sub quota), (before the
Board, at 9.00 am
at Academic Block, SMS Medical College, Jaipur)
All such candidates must present themselves physically along with all
original relevant
documents (only candidates who have deposited security amount) 		16.03.2025,
10.00 am Tentatively (Subject to receipt of Merit List from NBE)
Publication of Provisional Seat Matrix (after SD allotment) 16.03.2025,
Tentatively (Subject to receipt of Merit List from NBE)
Printing of the on-line application form after auto-locking of
the choices filled and saved by the candidates		 16.03.2025,
Tentatively (Subject to receipt of Merit List from NBE)
Publishing of the provisional allotment list 16.03.2025,
Tentatively (Subject to receipt of Merit List from NBE)
Printing of allotment letter, on-line, through website, by the
candidates		 17.03.2025,
Tentatively (Subject to receipt of Merit List from NBE)
Deposition of prescribed one year tuition fee by allotted
candidates through
NEFT and RTGS only (No other mode of fee deposition will be accepted)
Refer Important Advice for online payment of Security Amount/Tuition Fee
available at the
website		 17.03.2025
– 19.03.2025
by 12:00 noon,
Tentatively
(Subject to receipt of Merit
List from NBE)
Reporting at the allotted college desk at
Academic Block, SMS Medical College, Jaipur along with printout of allotment
letter and completion of all other formalities, required bonds etc. and 2
copies of application form along with Self attested photocopies (one set) of
all relevant documents as listed in information booklet		 17.03.2025
– 19.03.2025 by 6:00 pm, Tentatively
(Subject to receipt of Merit List from NBE)
Returning of Documents to candidates who have not been allotted
a seat in special stray vacancy round		 17.03.2025
to 19.03.2025 till 4:00 pm
Commencement of academic session 20.12.2024

For participation in special stray vacancy round, it is mandatory for candidates to present physically for document verification and submit all relevant original documents, as listed in the information booklet, with the board within stipulated time. Candidate whose documents are not verified and who does not submit his / her original documents, will not be allowed to participate in special stray vacancy round.

Candidate whose documents are already verified in stray vacancy round and who was not allotted any seat in stray vacancy round and whose documents are still lying with the Board at SMS Medical College, Jaipur, need not present physically again for document verification for special stray vacancy round and such a candidate is eligible (and if not ineligible otherwise) to participate in special stray vacancy round on filling fresh choices. Choices filled by such a candidate in stray vacancy round will not be considered for Special Stray Vacancy Round allotment.
Candidate shall also submit a bond in prescribed format mentioning that- (i) He/she will join the course within stipulated period. (ii) If he/she does not join the course, he/she will be liable to pay amount equal to the fee of entire course of the allotted college, to the allotted college (iii) If he/she fails to comply the above conditions, his/her original documents will be retained by the allotted college. In case of non-submission of bond, such candidate will not be allowed to participate in special stray vacancy round.
All PwD candidates must present themselves physically for document verification before the admission board on the notified date as per the notification and the list to be made available at the website.
All Eligible Senior Demonstrators who have deposited requisite security amount must present themselves physically with all applicable original documents for verification and allotment before the admission board on as per the notification available on website.
State eligibility criteria, as per clause 2(i) of instruction booklet for state quota seats shall be applicable up to round 3 allotment process. Any seat remaining vacant after round 3 shall be filled without applying the state eligibility criteria. All vacant seats will be available for allotment to all eligible candidates. Hence, Candidates must fill their choice for All India Quota Seats as well as State Quota Seats.
Candidate who joins the course on allotment in special stray vacancy round, shall not be allowed to resign the course (including returning of original documents) on or before the last date of admissions as scheduled by MCC/NMC.
Candidates allotted a seat in All India stray vacancy round/ Special Stray vacancy round is not eligible to participate in the State Special Stray vacancy round.
The candidates are advised to visit the websites regularly for registration and other relevant information.
Important
A candidate who deposits applicable security amount and fills choices in the stipulated time but fails to present himself/herself for document verification and submission along with requisite bond or his/her documents/bond are not found in order or has some deficiency of documents, then such a candidate will not be considered for allotments in Special Stray Vacancy round and his/her security amount will be refunded in due course of time.
If a candidate is allotted a seat in special stray vacancy round and does not join the allotted seat/college, he/she shall be debarred from participating in State Counselling Process for next one year, along with forfeiture of security amount.

Powered by WPeMatico

Health Ministry considers Faculty sharing to tackle medical teaching crisis

Contemplating a solution for faculty shortage, the Union Health Ministry is open to faculty sharing between medical colleges as it plans to add 10,000 new medical seats in the upcoming academic year i.e. 2025-2026, Business Standard has reported.

While speaking about this possibility, the Union Health Secretary Punya Salia Srivastava said that several experts had given recommendations to expand the faculty pool by permitting the sharing of the faculties between the medical colleges, especially in non-clinical subjects.

For more information, click on the link below:

Powered by WPeMatico

Maharashtra makes biometric attendance mandatory for healthcare staff

Through a recent circular, the Maharashtra Public Health Department has declared that biometric attendance will be mandatory for all medical officers and staff at government medical colleges and hospitals starting from April 1, 2025.

Additionally, they are also required to complete their online biometric registration on the official portal by March 31, 2025, as salary payments will only be disbursed based on biometric or face-reading attendance records.

For more information, click on the link below:

Powered by WPeMatico

NMC seeks report from DY Patil Medical College over Fake Files, Stipend Deductions, Poor Training

Taking cognizance of the several allegations raised concerning medical students, their training and the functioning of the institute, the National Medical Commission (NMC) has directed the DY Patil Medical College, Pune to look into the matter and furnish an action taken report within a week.

This comes after the Commission received a complaint alleging several deficiencies in the medical college including infrastructure and space constraints, irregularities and financial concerns, stipend deductions, issues with the district residency programme, deficiencies in medical training and patient care, and concerns regarding surgical training.

For more information, click on the link below:

Powered by WPeMatico

CDSCO Introduces Online CRO Registration Mandate from April 1, 2025, sets fee at Rs 5 lakh

New Delhi: With the mandated registration of clinical research organizations (CROs) effective from April 1, 2025, the Central Drug Regulator has set up the Sugam portal for online registration, allowing organizations to complete the process by making an online payment of Rs. 5 lakh.

The Ministry of Health and Family Welfare has published G.S.R. 581(E) dated 19th September 2024, wherein registration of Clinical Research Organization (CRO) has been made mandatory, effective from 1st day of April, 2025.

In keeping with the aforementioned, the Central Drug Standard Control Organisation (CDSCO), Directorate General of Health Service, Government of India, has declared in a notice that the Sugam Portal will be used to register Clinical Research Organisation (CRO) applications. A payment of Rs. 500000 can be made online to complete the registration process.

The notice stated, “The online registration of Clinical Research Organization (CRO) is now functional on SUGAM portal (www.cdscoonline.gov.in).”

“Applications for registration shall be submitted through SUGAM portal only along with the prescribed checklist of documents for the registration.” the notice added.

In accordance with the application for registration of Clinical Research Organization, the notice stated that the application for the Form CT07B is now available on the SUGAM Portal.

Furthermore, the notice added a user manual for the SUGAM-Ane-Governance solution, Online Forms Submission, CRO (Clinical Research Organization) by the Central Drugs Standard Control Organisation (CDSCO).

In line with the user manual, explaining the registration process for new users, the notice mentioned,

“New users can visit the SUGAM Portal and click on Login/Sign-Up. Navigate to sign-up here and select the registration purpose as “Clinical Research Organisation”.
Applicants may the fill the registration form as per the below screenshot.
Please note that the email address mentioned in the username will be used in future for further communication and for the verification of email address upon successful form submission.
Once the email address is verified, competent authority at CDSCO will further review the account request and grant approval accordingly. Once the account is approved by CDSCO, applicants may login into the SUGAM portal.”

In addition, regarding the Registration process for existing users, the notice stated,

‘Existing users on SUGAM Portal may submit are quest for additional role from user profile. Applicants may select role as “Clinical Research Organisation”.
It is important to complete the user profile to enable form submission.’

In continuation, the user manual added the process of filling out FORMCT-07B:

  • Applicants may login into the SUGAM Portal and click on the submit application page. Select “GCT Division” as the department and “Form CT07B” as the form. Click on the checkbox for the undertaking and click on “Proceed” button to proceed further.
  • After clicking on “Proceed” button form for CRO registration or renewal will open. Below mentioned details are to be submitted:

Purpose of Application

Application in Form CT-07B can be filled either with the registration purpose or renewal purpose.

Correspondence Address

Kindly select correspondence address from the drop down menu. In case the address details are not available then the same can be added from “Add Address Details” page from “User Profile” available in top left menu.

Details of Accreditation

Select option as “Yes” incase details of accreditation are available. Upon selecting “Yes” additional field will be visible where details of accreditation can be added. In case details of accreditation are not available, kindly select “No”.

  • Next, Click on the “Save” button to view the preview of the application form. Kindly ensure that the details mentioned in the preview page are in line with the details entered on the application page.
  • Next, Click on “Proceed to Checklist” button in order to view the checklist. Submit necessary documents on all checklist items and proceed further with the payment for the application.
  • On the payment page select “Online” as the mode of payment and the purpose.

 Fees for registration application is Rs.500000

  • Kindly ensure that the payment purpose is selected either as “CRO Registration” or “CRO Renewal” on payment page before generating deposit slip for bharat kosh.
  • Select desired challan from the drop down menu “Payment Reference Number” and click on “Submit” button to proceed further.
  • Final preview of the application will be displayed, kindly ensure that all details are correct, and payment related details are also captured correctly on preview page. Download system generated legal form by clicking on “Download PDF” button. System generated form needs to be duly signed by the applicant.
  • Click on “Next” button to proceed further with form submission.
  • Kindly upload duly signed copy of legal form on the final submission page and click on “Submit To CDSCO” button. Please note application number for future reference. Acknowledgement email for file submission will be sent on registered email address.
  • Application will be visible under “Submitted Applications” on applicant dashboard. Applicant may utilize e-vartalap functionality to communicate with concerned division during the course of file processing.
  • In case of any query applicant may raise ticket for IT-Helpdesk using “Raise Ticket for Help-Desk” option in top left menu

 

To review the full notice, click the below link:

https://medicaldialogues.in/pdf_upload/cro-registration-25-2-1-277369.pdf

Also Read:CDSCO Panel Approves Johnson and Johnson’s Protocol Amendment proposal for Teclistamab study

Powered by WPeMatico